Literature DB >> 20171514

Radiation dose-volume effects of optic nerves and chiasm.

Charles Mayo1, Mary K Martel, Lawrence B Marks, John Flickinger, Jiho Nam, John Kirkpatrick.   

Abstract

Publications relating radiation toxicity of the optic nerves and chiasm to quantitative dose and dose-volume measures were reviewed. Few studies have adequate data for dose-volume outcome modeling. The risk of toxicity increased markedly at doses >60 Gy at approximately 1.8 Gy/fraction and at >12 Gy for single-fraction radiosurgery. The evidence is strong that radiation tolerance is increased with a reduction in the dose per fraction. Models of threshold tolerance were examined. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20171514     DOI： 10.1016/j.ijrobp.2009.07.1753

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  102 in total

1.  A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme.

Authors:  Mizuhiko Terasaki; Tomoko Eto; Shinji Nakashima; Yosuke Okada; Etsuyo Ogo; Yasuo Sugita; Takashi Tokutomi; Minoru Shigemori
Journal:  J Neurooncol       Date:  2010-07-17       Impact factor: 4.130

Review 2.  Updates in outcomes of stereotactic radiation therapy in acromegaly.

Authors:  Monica Livia Gheorghiu
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Metachronous medulloblastoma and glioblastoma: Implications for clinical and technical aspects of re-irradiation.

Authors:  Vivek Verma; Rajesh R Kulkarni; Abhijeet R Bhirud; Nathan R Bennion; Rodney D McComb; Chi Lin
Journal:  Rep Pract Oncol Radiother       Date:  2015-11-21

Review 4.  Organ-sparing radiation therapy for head and neck cancer.

Authors:  XiaoShen Wang; ChaoSu Hu; Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2011-07-26       Impact factor: 66.675

Review 5.  Target delineation and optimal radiosurgical dose for pituitary tumors.

Authors:  Giuseppe Minniti; Mattia Falchetto Osti; Maximillian Niyazi
Journal:  Radiat Oncol       Date:  2016-10-11       Impact factor: 3.481

6.  Risk factors for radiation-induced optic neuropathy: a case-control study.

Authors:  Ian Ferguson; Julie Huecker; Jiayi Huang; Collin McClelland; Gregory Van Stavern
Journal:  Clin Exp Ophthalmol       Date:  2017-03-09       Impact factor: 4.207

7.  Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery.

Authors:  Putipun Puataweepong; Mantana Dhanachai; Ake Hansasuta; Somjai Dangprasert; Chomporn Sitathanee; Rawee Ruangkanchanasetr; Pornpan Yongvithisatid
Journal:  J Neurooncol       Date:  2018-05-30       Impact factor: 4.130

8.  Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.

Authors:  J Sherriff; J Tamangani; L Senthil; G Cruickshank; D Spooner; B Jones; C Brookes; P Sanghera
Journal:  Br J Radiol       Date:  2013-02       Impact factor: 3.039

9.  Effect of fluence smoothing on the quality of intensity-modulated radiation treatment plans.

Authors:  Puzhakkal Niyas; Kallikuzhiyil Kochunny Abdullah; Manthala Padannayil Noufal; Thekkedath Sankaran Nair
Journal:  Radiol Phys Technol       Date:  2016-03-07

10.  Delineating brachial plexus, cochlea, pharyngeal constrictor muscles and optic chiasm in head and neck radiotherapy: a CT-based model atlas.

Authors:  Domenico Genovesi; Francesca Perrotti; Marianna Trignani; Angelo Di Pilla; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Massimo Caulo; Massimo Savastano; Armando Tartaro; Antonio Raffaele Cotroneo; Giampiero Ausili Cèfaro
Journal:  Radiol Med       Date:  2014-08-05       Impact factor: 3.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.